Correlation Between Cannara Biotech and Amexdrug

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Amexdrug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Amexdrug into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and Amexdrug, you can compare the effects of market volatilities on Cannara Biotech and Amexdrug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Amexdrug. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Amexdrug.

Diversification Opportunities for Cannara Biotech and Amexdrug

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cannara and Amexdrug is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Amexdrug in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amexdrug and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Amexdrug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amexdrug has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Amexdrug go up and down completely randomly.

Pair Corralation between Cannara Biotech and Amexdrug

Assuming the 90 days horizon Cannara Biotech is expected to generate 116.92 times less return on investment than Amexdrug. But when comparing it to its historical volatility, Cannara Biotech is 7.65 times less risky than Amexdrug. It trades about 0.0 of its potential returns per unit of risk. Amexdrug is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  17.00  in Amexdrug on August 29, 2024 and sell it today you would lose (16.80) from holding Amexdrug or give up 98.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cannara Biotech  vs.  Amexdrug

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Amexdrug 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amexdrug has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Amexdrug is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Cannara Biotech and Amexdrug Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and Amexdrug

The main advantage of trading using opposite Cannara Biotech and Amexdrug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Amexdrug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amexdrug will offset losses from the drop in Amexdrug's long position.
The idea behind Cannara Biotech and Amexdrug pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings